Form 4 for KMX CARMAX INC
Accepted 2025-05-05 00:00:00 ET · period of report 2025-05-01 · accession 0001170010-25-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-05 | 2025-05-02 | KMX | Stuckey John M III | SVP, Gen Counsel, Sec | F - Tax | $66.71 | -370 | 1,827 | -17% | -$24.7K |
| D | 2025-05-05 | 2025-05-02 | KMX | Stuckey John M III | SVP, Gen Counsel, Sec | M - OptEx | — | +1,228 | 2,197 | +127% | — |
| D | 2025-05-05 | 2025-05-01 | KMX | Stuckey John M III | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +21.0K | 21.0K | New | $0 |
| D | 2025-05-05 | 2025-05-02 | KMX | Stuckey John M III | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | -1,579 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-02 | F | D | 370 | $66.71 | 1,827 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-02 | M | A | 1,228 | — | 2,197 | D | — | — | (F1) Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7777 times the number of MSUs in shares of Company common stock. |
| 3 | Derivative | Stock Options (Right to Buy) | 2025-05-01 | A | A | 20,968 | $0.00 | 20,968 | D | $65.52 · — to 2032-05-01 | 20,968 Common Stock | (F2) The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. (F3) The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. |
| 4 | Derivative | Restricted Stock Units | 2025-05-02 | M | D | 1,579 | $0.00 | 0 | D | — · — to — | 1,228 Common Stock | (F1) Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7777 times the number of MSUs in shares of Company common stock. (F4) The restricted stock units vested on May 2, 2025 and were settled in Company common stock. |